Company intelligence / Profile preview

Kinhely Bio-tech

Ownership: Private
Development stage: Commercial

Overview

Kinhely Bio-tech is a high-tech medical device company based in Shenzhen, China. It manufactures and markets interventional cardiovascular devices such as the Helios sirolimus-eluting coronary stent, which has received regulatory approval in China. The company is active and recognized as a national high-tech enterprise.[2][3] No clinical trial results are detailed in public sources; its main products are commercially available.

Therapeutic areas: Cardiovascular
Modalities: Device (specifically, drug-eluting stents)
Industry: Implantable Medical Devices

Drug pipeline

1 asset

sirolimus

Commercial

Indications: Coronary artery disease

Beyond the preview

Go deeper on Kinhely Bio-tech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kinhely Bio-tech.

Explore the full profile